NCT01910571View on ClinicalTrials.gov

Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Healthy

Interventions

DRUG

P7435

OTHER

Placebo

Trial Locations (1)

91911

Facility: Profil® Institute for Clinical Research, Inc., Chula Vista

All Listed Sponsors

collaborator

Profil Institute for Clinical Research, Inc.

OTHER

lead

Piramal Enterprises Limited

INDUSTRY

NCT01910571 - Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects | Biotech Hunter | Biotech Hunter